Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages

被引:93
作者
Kwon, Dong-Joo
Ju, Sung Mi
Youn, Gi Soo
Choi, Soo Young
Park, Jinseu [1 ]
机构
[1] Hallym Univ, Dept Biomed Sci, Chunchon 200702, Kangwon Do, South Korea
基金
新加坡国家研究基金会;
关键词
Flavokawain A; Inflammation; iNOS; COX-2; Macrophages; LPS; BLADDER-CANCER CELLS; ANTIINFLAMMATORY ACTIVITY; PIPER-METHYSTICUM; KAVA EXTRACTS; KAVALACTONES; INFLAMMATION; INVOLVEMENT; CHALCONE; ANXIETY; SAFETY;
D O I
10.1016/j.fct.2013.05.031
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Flavokawain A, a major constituent of chalcones derived from kava extracts, exerts various biological activities such as anti-tumor activities. In this study, we examined the suppressive effect of flavokawain A on LPS-induced expression of pro-inflammatory mediators and the molecular mechanisms responsible for these activities in the murine macrophages. Flavokawain A significantly suppressed expression of iNOS and COX-2, as well as the subsequent production of NO and PGE(2) in the LPS-stimulated RAW 264.7 cells. Flavokawain A significantly inhibited LPS-induced activation of NF-kappa B and AP-1 signaling pathways. In addition, flavokawain A inhibited activation of JNK and p38 MAPK which was responsible for expression of iNOS and COX-2 in the LPS-stimulated RAW 264.7 cells. Furthermore, flavokawain A suppressed LPS-induced expression of pro-inflammatory cytokines, such as TNF-alpha, IL-1 beta and IL-6. These results suggest that flavokawain A may exert anti-inflammatory responses by suppressing LPS-induced expression of pro-inflammatory mediators via blockage of NF-kappa B-AP-1-JNK/p38 MAPK signaling pathways in the murine macrophages. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:479 / 486
页数:8
相关论文
共 30 条
[1]   Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.) [J].
Anke, J ;
Ramzan, I .
JOURNAL OF ETHNOPHARMACOLOGY, 2004, 93 (2-3) :153-160
[2]   Prostaglandins and chronic inflammation [J].
Aoki, Tomohiro ;
Narumiya, Shuh .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (06) :304-311
[3]   Inflammation meets cancer, with NF-κB as the matchmaker [J].
Ben-Neriah, Yinon ;
Karin, Michael .
NATURE IMMUNOLOGY, 2011, 12 (08) :715-723
[4]   Kava-kava and anxiety: Growing knowledge about the efficacy and safety [J].
Bilia, AR ;
Gallon, S ;
Vincieri, FF .
LIFE SCIENCES, 2002, 70 (22) :2581-2597
[5]   Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages [J].
Chen, BC ;
Chen, YH ;
Lin, WW .
IMMUNOLOGY, 1999, 97 (01) :124-129
[6]   Kava kava: examining new reports of toxicity [J].
Clouatre, DL .
TOXICOLOGY LETTERS, 2004, 150 (01) :85-96
[7]  
Dharmaratne HRW, 2002, PHYTOCHEMISTRY, V59, P429
[8]   Type 2 diabetes as an inflammatory disease [J].
Donath, Marc Y. ;
Shoelson, Steven E. .
NATURE REVIEWS IMMUNOLOGY, 2011, 11 (02) :98-107
[9]   NF-κB activation by reactive oxygen species:: Fifteen years later [J].
Gloire, Geoffrey ;
Legrand-Poels, Sylvie ;
Piette, Jacques .
BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) :1493-1505
[10]   LPS induction of gene expression in human monocytes [J].
Guha, M ;
Mackman, N .
CELLULAR SIGNALLING, 2001, 13 (02) :85-94